Zimmer Biomet Holdings, Inc. (SIX: ZBH.SW) Stock Competitors & Peer Comparison

Zimmer Biomet Holdings, Inc. (SIX: ZBH.SW) plays a significant role within the Healthcare sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZBH.SW stands at 12.1B. In comparison, ABT.SW has a market cap of 125.5B. Regarding current trading prices, ZBH.SW is priced at CHF 62.50 on the SIX, while ABT.SW trades at CHF 72.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZBH.SW currently has a P/E ratio of 10.11, whereas ABT.SW's P/E ratio is 19.79. In terms of profitability, ZBH.SW's ROE is +0.06%, compared to ABT.SW's ROE of +0.11%. Regarding short-term risk, ZBH.SW is similarly volatile compared to ABT.SW. This indicates similar risk in terms of short-term price fluctuations for ZBH.SW.Check ABT.SW's competition here

Zimmer Biomet Holdings, Inc. (SIX: ZBH.SW) plays a significant role within the Healthcare sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZBH.SW stands at 12.1B. In comparison, SOON.SW has a market cap of 14.6B. Regarding current trading prices, ZBH.SW is priced at CHF 62.50 on the SIX, while SOON.SW trades at CHF 241.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZBH.SW currently has a P/E ratio of 10.11, whereas SOON.SW's P/E ratio is 26.92. In terms of profitability, ZBH.SW's ROE is +0.06%, compared to SOON.SW's ROE of +0.21%. Regarding short-term risk, ZBH.SW is less volatile compared to SOON.SW. This indicates lower risk in terms of short-term price fluctuations for ZBH.SW.Check SOON.SW's competition here

Zimmer Biomet Holdings, Inc. (SIX: ZBH.SW) plays a significant role within the Healthcare sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZBH.SW stands at 12.1B. In comparison, MED.SW has a market cap of 1.1B. Regarding current trading prices, ZBH.SW is priced at CHF 62.50 on the SIX, while MED.SW trades at CHF 90.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZBH.SW currently has a P/E ratio of 10.11, whereas MED.SW's P/E ratio is 73.75. In terms of profitability, ZBH.SW's ROE is +0.06%, compared to MED.SW's ROE of +0.05%. Regarding short-term risk, ZBH.SW is less volatile compared to MED.SW. This indicates lower risk in terms of short-term price fluctuations for ZBH.SW.Check MED.SW's competition here